CAMBRIDGE, Mass., Oct. 27 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. announced today that its presentations at the Company's Analyst & Investor Day will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com.
(Logo: NewsCom: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
At the Company's Analyst & Investor Day, Millennium management will discuss its refined Company strategy, clinical data and updates on its research and development programs. The presentations will be delivered beginning at 9:00 AM on Wednesday, November 2, 2005 from Le Parker Meridien Hotel in New York City. The webcast will be archived for 30 days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, its understanding of disease mechanisms, and its industrialized drug discovery platform, Millennium is seeking to develop breakthrough products.
Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.
Contact:
Kyle Kuvalanka
617-761-4734
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comMillennium Pharmaceuticals, Inc.CONTACT: Kyle Kuvalanka of Millennium Pharmaceuticals, Inc., +1-617-761-4734
Web site: http://www.millennium.com//
Company News On-Call: http://www.prnewswire.com/comp/114562.html/
